450 related articles for article (PubMed ID: 22327211)
21. Creation of "humanized" mice to study human immunity.
Pearson T; Greiner DL; Shultz LD
Curr Protoc Immunol; 2008 May; Chapter 15():15.21.1-15.21.21. PubMed ID: 18491294
[TBL] [Abstract][Full Text] [Related]
22. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
Hasgur S; Aryee KE; Shultz LD; Greiner DL; Brehm MA
Methods Mol Biol; 2016; 1438():67-78. PubMed ID: 27150084
[TBL] [Abstract][Full Text] [Related]
23. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
[TBL] [Abstract][Full Text] [Related]
24. The development and improvement of immunodeficient mice and humanized immune system mouse models.
Chen J; Liao S; Xiao Z; Pan Q; Wang X; Shen K; Wang S; Yang L; Guo F; Liu HF; Pan Q
Front Immunol; 2022; 13():1007579. PubMed ID: 36341323
[TBL] [Abstract][Full Text] [Related]
25. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
26. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P
Cytotherapy; 2010; 12(1):45-9. PubMed ID: 19929453
[TBL] [Abstract][Full Text] [Related]
27. Humanized SCID mouse models for biomedical research.
Pearson T; Greiner DL; Shultz LD
Curr Top Microbiol Immunol; 2008; 324():25-51. PubMed ID: 18481451
[TBL] [Abstract][Full Text] [Related]
28. Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution.
Abele-Ohl S; Leis M; Mahmoudian S; Weyand M; Stamminger T; Ensminger SM
Transpl Immunol; 2010 May; 23(1-2):59-64. PubMed ID: 20394817
[TBL] [Abstract][Full Text] [Related]
29. Visualization of the human CD4⁺ T-cell response in humanized HLA-DR4-expressing NOD/Shi-scid/γc(null) (NOG) mice by retrogenic expression of the human TCR gene.
Takahashi T; Katano I; Ito R; Ito M
Biochem Biophys Res Commun; 2015 Jan; 456(1):219-24. PubMed ID: 25462565
[TBL] [Abstract][Full Text] [Related]
30. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
[TBL] [Abstract][Full Text] [Related]
32. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
33. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.
Thanopoulou E; Cashman J; Kakagianne T; Eaves A; Zoumbos N; Eaves C
Blood; 2004 Jun; 103(11):4285-93. PubMed ID: 14962905
[TBL] [Abstract][Full Text] [Related]
34. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
35. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
36. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
[TBL] [Abstract][Full Text] [Related]
37. Humanized mice for studying human leukocyte integrins in vivo.
Kim SS; Kumar P; Ye C; Shankar P
Methods Mol Biol; 2012; 757():509-21. PubMed ID: 21909931
[TBL] [Abstract][Full Text] [Related]
38. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
Brehm MA; Bortell R; Diiorio P; Leif J; Laning J; Cuthbert A; Yang C; Herlihy M; Burzenski L; Gott B; Foreman O; Powers AC; Greiner DL; Shultz LD
Diabetes; 2010 Sep; 59(9):2265-70. PubMed ID: 20570944
[TBL] [Abstract][Full Text] [Related]
39. The utilization of humanized mouse models for the study of human retroviral infections.
Van Duyne R; Pedati C; Guendel I; Carpio L; Kehn-Hall K; Saifuddin M; Kashanchi F
Retrovirology; 2009 Aug; 6():76. PubMed ID: 19674458
[TBL] [Abstract][Full Text] [Related]
40. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
